On the other hand, previous studies reported that a high expression of AGXT can improve the prognosis of HCC patients, which indicates that AGXT may have other functions, such as promoting tumor immunity or other unfavorable factors to inhibit cancer progress. The gene discussed is AGXT; the disease is hepatocellular carcinoma.